S., T. (2014). Phase II study of paclitaxel (Taxol) and ifosfamide (Holoxan) in inoperable non-small-cell lung cancer.
Chicago Style CitationS., Thongprasert. Phase II Study of Paclitaxel (Taxol) and Ifosfamide (Holoxan) in Inoperable Non-small-cell Lung Cancer. 2014.
MLA CitationS., Thongprasert. Phase II Study of Paclitaxel (Taxol) and Ifosfamide (Holoxan) in Inoperable Non-small-cell Lung Cancer. 2014.
Warning: These citations may not always be 100% accurate.